Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-01

Clinical Trial Update: Efficacy Of PF-05089771 In Treating Postoperative Dental Pain [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating PF-05089771 for postoperative dental pain, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-05089771 (PF-05089771)

Snippet

Sponsor: Pfizer | Conditions: Postoperative Dental Pain | Phase 2 | Status: COMPLETED | Results posted: 2018-06-01